Literature DB >> 22546904

Dissecting novel virulent determinants in the Burkholderia cepacia complex.

George P Tegos1, Mark K Haynes, Herbert P Schweizer.   

Abstract

Prevention and control of infectious diseases remains a major public health challenge and a number of highly virulent pathogens are emerging both in and beyond the hospital setting. Despite beneficial aspects such as use in biocontrol and bioremediation exhibited by members of the Burkholderia cepacia complex (Bcc) some members of this group have recently gained attention as significant bacterial pathogens due to their high levels of intrinsic antibiotic resistance, transmissibility in nosocomial settings, persistence in the presence of antimicrobials and intracellular survival capabilities. The Bcc are opportunistic pathogens and their arsenal of virulence factors includes proteases, lipases and other secreted exoproducts, including secretion system-associated effectors. Deciphering the function of virulence factors and assessment of novel therapeutic strategies has been facilitated by use of diverse non-vertebrate hosts (the fly Drosophila melanogaster, the microscopic nematode Caenorhabditis elegans, the zebrafish and the greater Galleria mellonella wax moth caterpillar larvae). Researchers are now employing sophisticated approaches to dissect the virulence determinants of Bcc with the ultimate goal being the development of novel anti-infective countermeasures. This editorial will highlight selected recent research endeavors aimed at dissecting adaptive responses and the virulence factor portfolio of Burkholderia species.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546904      PMCID: PMC3442833          DOI: 10.4161/viru.19844

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  39 in total

Review 1.  Targeting virulence for antimicrobial chemotherapy.

Authors:  Yvonne M Lee; Fredrik Almqvist; Scott J Hultgren
Journal:  Curr Opin Pharmacol       Date:  2003-10       Impact factor: 5.547

2.  Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.

Authors:  Inês N Silva; Ana S Ferreira; Jörg D Becker; James E A Zlosnik; David P Speert; Ji He; Dalila Mil-Homens; Leonilde M Moreira
Journal:  Microbiology       Date:  2011-08-11       Impact factor: 2.777

3.  Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.

Authors:  Rebecca J Malott; Barbara R Steen-Kinnaird; Tracy D Lee; David P Speert
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Antimicrob Chemother       Date:  2009-07-23       Impact factor: 5.790

5.  Characterization of genes involved in biosynthesis of a novel antibiotic from Burkholderia cepacia BC11 and their role in biological control of Rhizoctonia solani.

Authors:  Y Kang; R Carlson; W Tharpe; M A Schell
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

Review 6.  Classification and identification of the Burkholderia cepacia complex: Past, present and future.

Authors:  Peter Vandamme; Peter Dawyndt
Journal:  Syst Appl Microbiol       Date:  2011-01-22       Impact factor: 4.022

7.  Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors:  S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A.

Authors:  Abimael Cruz-Migoni; Guillaume M Hautbergue; Peter J Artymiuk; Patrick J Baker; Monika Bokori-Brown; Chung-Te Chang; Mark J Dickman; Angela Essex-Lopresti; Sarah V Harding; Nor Muhammad Mahadi; Laura E Marshall; George W Mobbs; Rahmah Mohamed; Sheila Nathan; Sarah A Ngugi; Catherine Ong; Wen Fong Ooi; Lynda J Partridge; Helen L Phillips; M Firdaus Raih; Sergei Ruzheinikov; Mitali Sarkar-Tyson; Svetlana E Sedelnikova; Sophie J Smither; Patrick Tan; Richard W Titball; Stuart A Wilson; David W Rice
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

9.  Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.

Authors:  Karlene H Lynch; Paul Stothard; Jonathan J Dennis
Journal:  BMC Genomics       Date:  2010-10-25       Impact factor: 3.969

10.  Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.

Authors:  Pavel Drevinek; Matthew T G Holden; Zhaoping Ge; Andrew M Jones; Ian Ketchell; Ryan T Gill; Eshwar Mahenthiralingam
Journal:  BMC Infect Dis       Date:  2008-09-19       Impact factor: 3.090

View more
  7 in total

Review 1.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

2.  Wolbachia-associated bacterial protection in the mosquito Aedes aegypti.

Authors:  Yixin H Ye; Megan Woolfit; Edwige Rancès; Scott L O'Neill; Elizabeth A McGraw
Journal:  PLoS Negl Trop Dis       Date:  2013-08-08

3.  Efflux pump-mediated drug resistance in Burkholderia.

Authors:  Nicole L Podnecky; Katherine A Rhodes; Herbert P Schweizer
Journal:  Front Microbiol       Date:  2015-04-14       Impact factor: 5.640

Review 4.  Checks and Balances between Autophagy and Inflammasomes during Infection.

Authors:  Stephanie Seveau; Joanne Turner; Mikhail A Gavrilin; Jordi B Torrelles; Luanne Hall-Stoodley; Jacob S Yount; Amal O Amer
Journal:  J Mol Biol       Date:  2017-11-21       Impact factor: 6.151

5.  Antimicrobial Activity of Monoramnholipids Produced by Bacterial Strains Isolated from the Ross Sea (Antarctica).

Authors:  Pietro Tedesco; Isabel Maida; Fortunato Palma Esposito; Emiliana Tortorella; Karolina Subko; Chidinma Christiana Ezeofor; Ying Zhang; Jioji Tabudravu; Marcel Jaspars; Renato Fani; Donatella de Pascale
Journal:  Mar Drugs       Date:  2016-04-26       Impact factor: 5.118

6.  Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model.

Authors:  Pietro Tedesco; Marco Visone; Ermenegilda Parrilli; Maria Luisa Tutino; Elena Perrin; Isabel Maida; Renato Fani; Francesco Ballestriero; Radleigh Santos; Clemencia Pinilla; Elia Di Schiavi; George Tegos; Donatella de Pascale
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

7.  Outer membrane vesicles produced by Burkholderia cepacia cultured with subinhibitory concentrations of ceftazidime enhance pro-inflammatory responses.

Authors:  Se Yeon Kim; Mi Hyun Kim; Joo Hee Son; Seung Il Kim; Sung Ho Yun; Kyeongmin Kim; Shukho Kim; Minsang Shin; Je Chul Lee
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.